Furthermore, the discovery of certain proteins (MYH2, MYL1, MYL2, MYH7) and microRNAs (hsa-let-7d-5p) linked to the advancement of breast cancer offers new, prospective biomarkers for diagnosis and therapy, opening the door for innovative therapeutic approaches. This evidence concerns the gene MYH7 and breast cancer.